Kidney Week 2025 Annual Meeting
Availability
On-Demand
Cost
$0.00
Contains (149)
An IOTA of Sense: What Should Nephrology Professionals Know About the Increasing Organ Transplant Access Model?
A Lifespan Approach to Pediatric Hypertension: Guiding Care from Youth to Adulthood
Addressing Symptoms in Dialysis-Dependent Kidney Disease
Beyond Human Leukocyte Antigens: Integrating Genetics into Living Donor Kidney Transplantation
AKI and Hepatorenal Syndrome: Diagnosis, Management, and Treatment
AKI Advances: Biomarkers, Outcomes, and Clinical Trials
Better Kidney Care Requires Better Payment Systems
Advancing Hypertension Care: Role of Renal Denervation
Aldosterone-Dependent and -Independent Mechanisms in Sodium Transport and Hypertension
Changing Landscape for Management of Vasculitis, Including the Robert W. Schrier, MD, Endowed Lectureship
Breaking Barriers: Advances in Understanding and Treating Complement-Mediated Kidney Diseases
AKI Everywhere All at Once: Risks, Trajectories, and Practice Patterns
Nephrology Workforce: The Future Is Now
Approach to Hypertension Treatment: Special Groups, Including the Sharon Silbiger, MD, Endowed Lectureship
APOL1-Mediated Kidney Disease: A Blueprint for Precision Nephrology?
Effects of Diabetes and Diabetes Therapies on the Skeleton
Considerations for Incorporating Hemodiafiltration into Dialysis Care
AKI Progression and Resolution: Cellular and Molecular Insights
Opening Plenary: ASN President's Address, State-of-the-Art Lecture, Featured High-Impact Clinical Trials
Banff Classification: Updates, Progress, and Challenges for Clinicians and Pathologists
Best in Show: Literature Review in Kidney Transplantation - Honoring Roy First
Extracellular Vesicle-Based Therapeutics for CKD: The Way of the Future
Expanding Therapeutic Horizons in IgAN
Artificial Intelligence and Data Science Transforming Kidney Care: From Algorithms to Action
Plenary: ASN Midcareer Awards, John P. Peters Award, Homer W. Smith Award, Donald W. Seldin Young Investigator Award and Address, State-of-the-Art Lecture
Cardiovascular-Kidney-Metabolic Syndrome Case Discussions: From Trials to Patient Management, Including the Garabed Eknoyan, MD, Endowed Lectureship
Best of ASN Journals: JASN, CJASN, and Kidney360
Have We Fully Exploited the Potential of SGLT2 Inhibitors for the Treatment of CKD?
Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitors, CVD, and Hyporesponsiveness to Erythropoiesis-Stimulating Agents in ESKD
CKD: Advancing Epidemiology, Risk Factors, and Prevention
Plenary: ASN President's Medal, Robert G. Narins Award, Belding H. Scribner Award, Barbara T. Murphy Award, State-of-the-Art Lectures
Case Studies in Glomerular Diseases 2025
Best of the Journal of the American Medical Association and the New England Journal of Medicine
Histological Lessons from Modern Biopsy Cohort Studies
Inflammation at the Crossroads: Atherosclerotic Cardiovascular Disease and CKD Interactions
CKD: Exploring Intertwined Mechanisms of Disease Progression
Plenary: In Memoriam, State-of-the-Art Panel "Xenotransplantation Advances"
Choosing the Optimal Dialysis Modality for Difficult Situations
Big Questions in Maintenance Dialysis
Hot Topics in Lupus Nephritis
Management of RAAS Inhibitor Therapy After Hyperkalemia in Patients with CKD and Heart Failure
Dialysis Vascular Access: From Basic Discovery to Translational Science
Promoting Justice in Kidney Health, Including the Christopher R. Blagg, MD, Endowed Lectureship in Kidney Diseases and Public Policy
CKD in the US Hispanic/Latino Population
Bridging Gaps in CKD Care: Advancing Health Equity Through Policy, Practice, and Community Action
Influence of Lower Urinary Tract on Pediatric Kidney Health
Optimizing B Cell-Targeted Therapies for Lupus Nephritis: Strategies for Success and Pitfalls to Avoid
CKD: Identifying Risks and Optimizing Outcomes
Two Years of Change in the United States: Congress, the White House, and the Policies Impacting Kidney Care for Private Practice and Academia Alike
Clinical Management of Cardiovascular-Kidney-Metabolic Diseases: Protecting Kidney Health
Bringing New Technologies to Dialysis Care
Iron and Mineral Metabolism: A Complex Relationship, Including the Jack W. Coburn, MD, Endowed Lectureship
Prevention of CKD-Associated Hyperphosphatemia in 2025: What Are the Risks and Benefits?
Diversity and Equity in Kidney Health: Research and Cases
Controversies in Glomerular Disease Therapeutics
Cardiovascular-Kidney-Metabolic Interactions and More: Multimorbidity and the Era of Integrated Care, Including the Barry M. Brenner, MD, Endowed Lectureship
Membranous Nephropathy: From Science to Personalized Patient Care - Honoring William Couser
Proteinuria and eGFR as Clinical Trial End Points in FSGS
Exploring Dietary, Exercise, and Microbiome Interventions in CKD
Controversies in the Management of Kidney Dysfunction in Advanced Liver Disease
CKD in Limited-Resource Settings: Epidemiology, Clinical Presentations, and Treatment
Moving the Needle in Childhood Nephrotic Syndrome
Role of Complement in ANCA-Associated Vasculitis
Fluids and Electrolytes: Bench and Bedside
Decision-Making at Transitions Along the Dialysis Pathway
Clinical-Pathologic-Molecular Correlations in Diabetic Kidney Disease
Prenatal and Postnatal Effects on the Kidneys: Mechanisms and Innovative Therapies
Genetics of Complex Kidney Traits
Disaster and Humanitarian Emergencies: Ways the Nephrology Team Can Best Manage a Crisis
Decoding AKI: The Omics Revolution
Seeing Is Believing: Advancing Tissue Imaging Technologies for Transformative Diagnostics
Glomerular Disease Outcomes: Measuring What Matters
Don't Let It Go to Your Head: Hyponatremia and the Brain - Honoring Nicolaos Madias
Dialysis-Dependent AKI: Therapies for Kidney Recovery and Improving Cardiovascular Outcomes
Sepsis-Associated AKI: Pathophysiology to Subphenotypes to Treatments
Glomerular Precision Nephrology: Novel Mechanisms, Biomarkers, and Therapeutic Targets
Fluid Therapy in Critical Care: Innovations, Controversies, and Future Directions
Emerging Insights on the Evaluation of Kidney Stone Risk
Therapeutic Landscape for the Management of Diabetic Kidney Disease: What's Next After SGLT2 Inhibition?
Glomerular Targeted Therapies: The New Era
Genetic Testing in the Nephrology Clinic
Emerging Mechanisms of AKI in Cardiovascular-Kidney-Metabolic Syndrome
Therapeutics in AKI: From Bench to Bedside, Including the Burton D. Rose, MD, Endowed Lectureship
Hemodialysis: Novel Interventions
Glomerular Diseases and Women's Health, Including the Michelle P. Winn, MD, Endowed Lectureship
Extending Glomerular Function in Aging
Translating Evidence into Real-World Clinical Scenarios in AKI and Critical Care Nephrology
High-Impact Clinical Trials - 1
Guidance for Outpatient Dialysis for AKI: How to Optimize Outcomes
Genetic Insights into Tubular Function: Unlocking the Mysteries of Chronic Electrolyte Disorders
Upping Our Game: Advances in Clinical Trials for Pediatric Kidney Diseases
High-Impact Clinical Trials - 2
Heart Failure Across the Spectrum of CKD: Mechanisms and Treatment
Genetics of Complex Kidney Traits, Big Data, and Multi-Omics
Hypertension and Cardiorenal Disease: Novel Mechanisms and Therapeutic Targets
How to Deliver Precision CRRT: Optimizing Dose, Ultrafiltration, and Anticoagulation
Home Hemodialysis Therapies in Older and Frail Adults
Innovations in Pediatric Nephrology and Kidney Development
Hyperkalemia in the Time of Zirconium and Patiromer
How to Combat AKI: Control Damage or Promote Repair?
Kidney Disease with Diabetes: Translational Science Breakthroughs
Increasing Kidney Transplantation: State of the Art, Including the Barbara T. Murphy, MB BAO BCh, Endowed Lectureship
Immune-Mediated Kidney Diseases in Children
Late-Breaking Research Orals - 1
Is Equity in Access to Home Dialysis Feasible?
Immunity, Autoimmunity, and Hypertensive Kidney Damage
Late-Breaking Research Orals - 2
Management of Patients with Challenging Dialysis Access
Impacts of Nicotine, Cannabinoids, and Opioids on Kidney Health
Late-Breaking Research Orals - 3
Nephrology Quiz and Questionnaire 2025
Incretin-Based Therapies in Nephrology
Monogenic Kidney Disease: Mechanistic Insights and Therapeutic Approaches
Nutrition and CKD: From Prevention of Progression to Post-Transplant Diet
Integrative Omics Approaches for Proactive and Precision CKD Treatment: From Genotype to Phenotype
New Developments in Bones, Stones, and Mineral Metabolism
Onconephrology in the Mainstream: Bedside Application of Recent Advances
Kidney Tissue Genomics Revolution
Onconephrology: Updates, Therapies, and Mechanisms
Patient-Reported Outcomes: Why (and How) Should They Be Implemented?
Kidney Transplant Modernization: Policies, Allocation, and Strategies
Pathology: Novel Mechanisms and Modalities
Pediatric Onconephrology
Leading Edge of Therapeutic Development in Cystic Kidney Diseases
Precision Medicine in Diabetic Kidney Disease: Biomarkers, Combination Therapies, and Treatment Response Prediction
Point-of-Care Ultrasonography in Nephrology: Current Practice and Future Directions
Mechanistic Insights on Urinary Stone Formation
Transplantation: Basic Science Innovations and Advances
Proteinuria and Hypertension in Patients with Cancer
Navigating Human Leukocyte Antigens
Transplantation: Clinical Controversies in Donation, Access, Monitoring, and Treatment
Re-Exploring Peritoneal Dialysis as a Treatment Option for AKI
New Paradigms in Proteinuric Kidney Diseases
What's New at Home (Dialysis)?
Renal Biopsy: Clinical Correlations 2025
Novel Immune Modulators of Allograft Rejection
Resistant Hypertension: Newer Therapies
Novel Therapeutic Approaches and Pathways for Phosphate and Fibroblast Growth Factor 23 Regulation
Success Stories in Glomerular Diseases: From Bench to Bedside, Including the Celeste Castillo Lee Endowed Lectureship
Post-Transcriptional and Post-Translational Processing in Glomerular Diseases
Young People, Grown-Up Diseases: Approaches to "Adult" Kidney Diseases in Children and Young Adults
Renin-Angiotensin System and Kidney Function: Mechanisms, Insights, and Implications
Revisiting Mendelian Kidney Diseases: Understanding Phenotype Variability
Role of the Immune System in CKD
Sex and Kidney Metabolism: A New Frontier to Better Understand and Treat Kidney Diseases
Small Molecules to Modulate CKD-MBD
Team Science and Multi-Omics in the Quest to Cure Diabetic Kidney Disease
The Far Side of the Nephron: New Insights into Basolateral Transport and Signaling
Unraveling the Mysteries of AKI: Therapeutic Strategies on the Horizon

ASN Kidney Week is the world’s premier nephrology meeting. Leading experts share new approaches to health care, research, education, policy, and more.

Learning Objectives:
At the conclusion of this activity, the participant should be able to:

  • Identify recent discoveries in basic, translational, and clinical research in nephrology;
  • Construct new research questions based on updated scientific and clinical advances in nephrology-related disciplines; and
  • Translate recent advances in the areas of general nephrology, dialysis, transplantation, and hypertension into new standards and approaches to clinical care of patients with kidney diseases and related disorders.

Target Audience:

  • Physicians
  • Researchers
  • Medical and Other Trainees – Including medical students, residents, graduate students, post-docs, and fellows
  • Nurses and Nurse Practitioners
  • Pharmacists
  • Physician Assistants
  • Other Health Care Professionals

Commerical Support
ASN thanks the following supporters of Kidney Week 2025 On-Demand: Medtronic, Vera Therapeutics, Vertex Pharmaceuticals.

Privacy Policy/Confidentiality   
http://www.asn-online.org/terms/privacy.aspx    

ASN Medical Disclaimer      
http://www.asn-online.org/terms/medical-disclaimer.aspx    

ASN Contact Information
For any questions concerning this activity, please contact ASN at 202-640-4660 or education@asn-online.org.

Accreditation Statement

JA logo

In support of improving patient care, the American Society of Nephrology is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

AMA Credit Designation Statement – Physicians:
The American Society of Nephrology designates this other activity (blended learning) for a maximum of 65.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ANCC Credit Designation Statement - Nurses:  This CE activity is approved for 65.00 ANCC contact hours. 

ACPE Credit Designation Statement - Pharmacists: This CE activity is approved for 65.00 contact hours.

NCCPA Credit Designation Statement – Physician Assistants:
NCCPA accepts AMA PRA Category 1 Credits™ from organizations accredited by ACCME or a recognized state medical society.
Physician Assistants may receive a Certificate of Participation that states this activity has been approved for up to 65.00 AMA PRA Category 1 Credits™.

ABIM MOC Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 65.00 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to Joint Accreditation for the purpose of granting ABIM MOC credit.

Method of Participation

  • Participate in the Annual Meeting (verification required).
  • In the activity, click the Questionnaire tab, and complete the Demographics Questionnaire.
  • Select the Evaluation tab.
    • Complete the General Evaluation.
    • Click the date sub-headers to expand and complete the session evaluations.
  • Select the Claim Credit tab. Use the Credit Selection dropdown to select your applicable credit type. If none apply, select None of the Above - Print Participation Certificate.
  • If a CE credit type is selected:
    • The number of credits is defaulted to the maximum amount of 75. Adjust based on your actual participation.
      • Select the Claim button.
      • Select the View Certificate button. It may take up to 15 minutes for your certificate to show.
    • If None of the Above - Print Participation Certificate is selected:
      • Select I understand the above - continue to participation certificate.
      • Select Get Certificate. 

Maintenance of Certification (MOC) Points
The Kidney Week Annual Meeting offers MOC points for American Board of Internal Medicine (ABIM) and American Board of Pediatrics (ABP) Diplomates with the completion of a reflective statement and commitment-to-change questions in this activity's evaluation.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:

  • 65 MOC points in the ABIM's MOC program; and
  • 65 MOC points in the ABP's MOC program.

Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity.

MOC Requirements

To obtain American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) Points, physicians must meet the following criteria: 

  • Be certified by ABIM in internal medicine and/or nephrology and enrolled in the ABIM MOC program.
  • Complete a reflective statement and commitment-to-change questions to be reviewed and approved by ASN education staff.

CME/CNE/CPE/MOC Termination Date: December 17, 2025, 11:59 PM ET.
*After this date, ABIM and ABP MOC Points will not be available.

ASN thanks the hundreds of faculty and experts who contributed to Kidney Week's educational content.

ASN Disclosure Policy
In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ASN requires all individuals in a position to control content for Kidney Week to disclose all financial relationships with ineligible companies.

All disclosed financial relationships were reviewed by ASN. Any relevant financial relationships with ineligible companies were identified and mitigated prior to the activity.

View the ASN Disclosure Policy here.

Disclosures were provided on the ASN website and during the sessions. View the disclosure list for this activity here.

For a successful viewing experience, the following hardware and software are required:
  • Broadband cable, DSL, or high-speed internet connection
  • Please use the latest version of Google Chrome for the best viewing experience. Mozilla and Safari can also be used; however, Microsoft Edge is not recommended. Please check the ASN auto-detect settings page.
  • 533 MHz or faster processor
  • 512 MB RAM or higher
  • Adobe Reader (free download)
  • Computer which can play MP3 files
  • Apple iPad/iPhone running HTML5
  • Android devices  
Note: If you are experiencing technical difficulties, please contact education@asn-online.org for assistance.